Insurer margins squeezed as procedures delayed by Covid now go ahead. Market's overreacted to this. Still a good long-term hold. Confident in management. Over next 5-10 years, healthcare spending will be double GDP growth.
It is both a growth and value stock being a health insurer for corporations. It also provides management for the Federal Government through Medicare and Medicaid as well as its own networks. It is slowly becoming more vertically integrated. Being more on the defensive side it helps to balance his portfolio. Buy 21 Hold 4 Sell 0
Excellent business with good long term prospects.
Very strong balance sheet.
Large health insurance company with ~45M customers.
Strong management team that is good at running business.
Healthcare notoriously left out of most recent high-beta rally. Don't give up. Don't chase low-quality, high-beta companies just because they're going up for 6 weeks. Go with good quality companies, and you will be rewarded. He's sticking with it. Demographic tailwind, 6% FCF yield, expects $33 EPS in 2023 which is a 15x PE.
Elevance Health Inc is a American stock, trading under the symbol ELV-N on the New York Stock Exchange (ELV). It is usually referred to as NYSE:ELV or ELV-N
In the last year, 5 stock analysts published opinions about ELV-N. 4 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Elevance Health Inc.
Elevance Health Inc was recommended as a Top Pick by on . Read the latest stock experts ratings for Elevance Health Inc.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
5 stock analysts on Stockchase covered Elevance Health Inc In the last year. It is a trending stock that is worth watching.
On 2023-11-29, Elevance Health Inc (ELV-N) stock closed at a price of $468.705.
Continues to like it. Healthcare has been in the penalty box the past year. ELV was Anthem. It insures 48 million Americans. Growing 15% annually, but trades at only 14x earnings.